Biohaven Ltd. (BHVN)
NYSE · Manufacturing · Pharmaceutical preparations
BHVN price, last 12 months
Key stats
- Previous close
- $12.90
- Open
- $13.24
- Day range
- $13.00 – $14.27
- 52-week range
- $8.03 – $18.24
- Volume
- 3.3M
- Avg volume (20 days)
- 2.5M
- Market cap
- $2.1B
Performance
Technicals and fundamentals
About Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder and others. Its pipeline products include: BHV-2000, BHV-7000, BHV-2100, BHV-8000, BHV-1310, BHV-1300, BHV-1400, BHV-1600, BHV-1530, and BHV-1500.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE
- Market cap
- $2.1B